Starting in early 2018, the National Institutes of Health will spend $70 million over 5 years to find new and effective treatments and prevention techniques for Alzheimer’s and related dementias.

Developing effective treatments for Alzheimer’s and related dementias has proven extremely challenging. However, with recent advances in basic science and the identification of potential therapeutic targets, the number and types of possible therapies for testing have grown and are expected to increase significantly. Now, scientists are seeking to intervene as early as possible in disease development, before memory loss and other clinical signs of decline appear.

As many as 5.3 million people in the U.S. age 65 and older already show signs of Alzheimer’s. Without effective intervention, those numbers are projected to rise to between 11 and 16 million by 2050. These studies can’t come soon enough!